Hereby I would like to confirm the strong interest of Instituto de Investigación Biomédica de Málaga-Health Research Institute of Malaga (IBIMA), Spain; with regard to the European Innovation Partnership on Active and Healthy Ageing. The EIP-AHA will lead towards the increase of the understanding an implementation of effectiveness in drug adherence and creating an adequete framework for an active and healthy ageing . This initative is of great interest to our institution as we are potential end-users of the results and we have the capaibility to implement and to conducting pilots testing the ICT solutions in proof.